Literature DB >> 23729594

Increased expression of STK25 leads to impaired glucose utilization and insulin sensitivity in mice challenged with a high-fat diet.

Emmelie Cansby1, Manoj Amrutkar, Louise Mannerås Holm, Annika Nerstedt, Azadeh Reyahi, Elin Stenfeldt, Jan Borén, Peter Carlsson, Ulf Smith, Juleen R Zierath, Margit Mahlapuu.   

Abstract

Partial depletion of serine/threonine protein kinase 25 (STK25), a member of the Ste20 superfamily of kinases, increases lipid oxidation and glucose uptake in rodent myoblasts. Here we show that transgenic mice overexpressing STK25, when challenged with a high-fat diet, develop reduced glucose tolerance and insulin sensitivity compared to wild-type siblings, as evidenced by impairment in glucose and insulin tolerance tests as well as in euglycemic-hyperinsulinemic clamp studies. The fasting plasma insulin concentration was elevated in Stk25 transgenic mice compared to wild-type littermates (4.9±0.8 vs. 2.6±0.4 ng/ml after 17 wk on high-fat diet, P<0.05). Overexpression of STK25 decreased energy expenditure during the dark phase of observation (P<0.05), despite increased spontaneous activity. The oxidative capacity of skeletal muscle of transgenic carriers was reduced, as evidenced by altered expression of Cpt1, Acox1, and ACC. Hepatic triglycerides and glycogen were elevated (1.6- and 1.4-fold, respectively; P<0.05) and expression of key enzymes regulating lipogenesis (Fasn), glycogen synthesis (Gck), and gluconeogenesis (G6pc, Fbp1) was increased in the liver of the transgenic mice. Our findings suggest that overexpression of STK25 in conditions of excess dietary fuels associates with a shift in the metabolic balance in peripheral tissues from lipid oxidation to storage, leading to a systemic insulin resistance.

Entities:  

Keywords:  metabolic balance; serine/threonine protein kinase 25; type 2 diabetes

Mesh:

Substances:

Year:  2013        PMID: 23729594     DOI: 10.1096/fj.13-228494

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  17 in total

1.  The MST3/STK24 kinase mediates impaired fasting blood glucose after a high-fat diet.

Authors:  Cristina Iglesias; Ebel Floridia; Miriam Sartages; Begoña Porteiro; María Fraile; Ana Guerrero; Diana Santos; Juan Cuñarro; Sulay Tovar; Rubén Nogueiras; Celia M Pombo; Juan Zalvide
Journal:  Diabetologia       Date:  2017-09-27       Impact factor: 10.122

2.  Lipid droplet-associated kinase STK25 regulates peroxisomal activity and metabolic stress response in steatotic liver.

Authors:  Annika Nerstedt; Yeshwant Kurhe; Emmelie Cansby; Mara Caputo; Lei Gao; Egor Vorontsov; Marcus Ståhlman; Esther Nuñez-Durán; Jan Borén; Hanns-Ulrich Marschall; Douglas G Mashek; Darren N Saunders; Carina Sihlbom; Andrew J Hoy; Margit Mahlapuu
Journal:  J Lipid Res       Date:  2019-12-19       Impact factor: 5.922

3.  First genome-wide association study of 99 body measures derived from 3-dimensional body scans.

Authors:  Andreas Kühnapfel; Peter Ahnert; Katrin Horn; Holger Kirsten; Markus Loeffler; Markus Scholz
Journal:  Genes Dis       Date:  2021-02-16

4.  Protein kinase STK25 controls lipid partitioning in hepatocytes and correlates with liver fat content in humans.

Authors:  Manoj Amrutkar; Matthias Kern; Esther Nuñez-Durán; Marcus Ståhlman; Emmelie Cansby; Urszula Chursa; Elin Stenfeldt; Jan Borén; Matthias Blüher; Margit Mahlapuu
Journal:  Diabetologia       Date:  2015-11-09       Impact factor: 10.122

5.  Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model.

Authors:  Manoj Amrutkar; Emmelie Cansby; Urszula Chursa; Esther Nuñez-Durán; Belén Chanclón; Marcus Ståhlman; Vincent Fridén; Louise Mannerås-Holm; Anna Wickman; Ulf Smith; Fredrik Bäckhed; Jan Borén; Brian W Howell; Margit Mahlapuu
Journal:  Diabetes       Date:  2015-04-06       Impact factor: 9.461

6.  Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice.

Authors:  Esther Nuñez-Durán; Mariam Aghajan; Manoj Amrutkar; Silva Sütt; Emmelie Cansby; Sheri L Booten; Andrew Watt; Marcus Ståhlman; Norbert Stefan; Hans-Ulrich Häring; Harald Staiger; Jan Borén; Hanns-Ulrich Marschall; Margit Mahlapuu
Journal:  Hepatol Commun       Date:  2017-11-20

7.  Protein kinase STK25 aggravates the severity of non-alcoholic fatty pancreas disease in mice.

Authors:  Esther Nuñez-Durán; Belén Chanclón; Silva Sütt; Joana Real; Hanns-Ulrich Marschall; Ingrid Wernstedt Asterholm; Emmelie Cansby; Margit Mahlapuu
Journal:  J Endocrinol       Date:  2017-04-25       Impact factor: 4.286

8.  Overexpressing the novel autocrine/endocrine adipokine WISP2 induces hyperplasia of the heart, white and brown adipose tissues and prevents insulin resistance.

Authors:  John R Grünberg; Jenny M Hoffmann; Shahram Hedjazifar; Annika Nerstedt; Lachmi Jenndahl; Johannes Elvin; John Castellot; Lan Wei; Sofia Movérare-Skrtic; Claes Ohlsson; Louise Mannerås Holm; Fredrik Bäckhed; Ismail Syed; Fatima Bosch; Alan Saghatelian; Barbara B Kahn; Ann Hammarstedt; Ulf Smith
Journal:  Sci Rep       Date:  2017-02-27       Impact factor: 4.379

9.  STE20-Type Protein Kinase MST4 Controls NAFLD Progression by Regulating Lipid Droplet Dynamics and Metabolic Stress in Hepatocytes.

Authors:  Mara Caputo; Emmelie Cansby; Sima Kumari; Yeshwant Kurhe; Syam Nair; Marcus Ståhlman; Nagaraj M Kulkarni; Jan Borén; Hanns-Ulrich Marschall; Matthias Blüher; Margit Mahlapuu
Journal:  Hepatol Commun       Date:  2021-03-16

10.  Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice.

Authors:  Shanthadevi Udayappan; Louise Manneras-Holm; Alice Chaplin-Scott; Clara Belzer; Hilde Herrema; Geesje M Dallinga-Thie; Silvia H Duncan; Erik S G Stroes; Albert K Groen; Harry J Flint; Fredrik Backhed; Willem M de Vos; Max Nieuwdorp
Journal:  NPJ Biofilms Microbiomes       Date:  2016-07-06       Impact factor: 7.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.